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a,b EgyptIntroduction: Epistaxis is the most common otorhinolaryngological emergency. Whether there is an association or
cause and effect relationship between epistaxis and hypertension is a subject of longstanding controversy.
Objective: The aim of our study is to evaluate the relationship between epistaxis and hypertension.
Materials and methods: This study was conducted at Olaya Medical Center (Riyadh) during the period between
May 2013 and June 2014. A total of 80 patients were divided into two groups: Group A consisted of 40 patients who
presented with epistaxis, and Group B consisted of 40 patients who served as a control group. Twenty-four-hour
ambulatory blood pressure monitoring (ABPM) was performed for all patients. Patients were followed up for a per-
iod of three months.
Results: Readings of blood pressure (BP) were similar between the two groups regarding BP at presentation,
ABPM, and BP at three months. There was a higher number of attacks in patients with history of hypertension.
There was highly significant positive correlation between number of attacks of epistaxis and BP readings. Systolic
BP at presentation was higher in patients who needed more complex interventions such as pack, balloon or cautery
than those managed by first aid.
Conclusion: We found no definite association between epistaxis and hypertension. Epistaxis was not initiated by
high BP but was more difficult to control in hypertensive patients.
 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
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The term ‘epistaxis’ is Latin, derived from theGreek, epistazein (epi – above, over; stazein –
to drip) [1]. Epistaxis is a common symptom of
diverse conditions which may present as mild
recurrent bleeds or severe life threatening rhino-
logical emergency and may pose a challenge toeven a skilled otolaryngologist [2]. Globally,
the true incidence remains unknown, but it is
estimated that 60% of the population will have at
least one episode of epistaxis in their lifetime,
and 6% of them will seek medical attention. A
slight male preponderance with 55% male and
45% female has been reported. Epistaxis is rare
in neonates but common among children and
Abbreviations
ABPM ambulatory blood pressure monitoring
BMI body mass index
BP blood pressure
d diastolic
dBP diastolic blood pressure
DM diabetes mellitus
ENT ear, nose and throat
HTN hypertension
s systolic
sBP systolic blood pressure
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a bi-modal age presentation [3].
Hypertension is increasing in prevalence in
Saudi Arabia, affecting more than one fourth of
the adult Saudi population [4]. It is still
doubtful whether a connection exists between epi-
staxis and hypertension [6]. The prevalence rates
of hypertension among patients with epistaxis
range from 17 to 67% [6]. Whether there
is an association or cause and effect relationship
between epistaxis and hypertension is a subject
of longstanding controversy [7].
Twenty-four-hour ambulatory BP monitoring
(ABPM) is more valuable for predicting prognosis
than other measures, as it more accurately
assesses the risk of cardiovascular disease than
measurements of BP made during clinic or office
visits, and also ABPM is closely related to damage
of target organs [8]. Twenty-four-hour ABPM
enables the continuous observance of changes in
BP during activities of daily life, measuring
automatically at specific time intervals, and there-
fore allowing for more accurate BP measurements
[9]. Serious spontaneous epistaxis may also
be the presenting sign of underlying true hyper-
tension in 43% of patients with no history of
hypertension. However, hypertension per se
does not appear to be a significant causal factor
and/or factor of severity in serious spontaneous
epistaxis [10].
Blood vessels in the nose run superficially
through the easily-damaged mucosa and are
therefore relatively unprotected [11]. The arterial
hypertension would determine structural altera-
tions of the nasal vessels similar to those verified
in the cerebral circulation and retinal examination
[12]. The etiologic role of hypertension in epistaxis
is not certain. It is possible that hypertension
causes arteriolosclerotic nasal vascular changes
that predispose hypertensives to increased sus-
ceptibility to epistaxis [7]. Fundus examination of
hypertensive epistaxics has demonstrated high
prevalence of hypertensive retinal arteriolosclero-
sis in patients with epistaxis, which is an index of
arteriolosclerotic changes in other parts of the
body [13]. Similarly, an association between dura-
tion of hypertension and left ventricular hypertro-
phy and nasal artery enlargement determined
by rhinoscopy has been described among
hypertensives with history of epistaxis, indicating
that long lasting hypertension might contribute to
epistaxis [14].
The aim of our study is to evaluate the relation-
ship between epistaxis and hypertension, its
recurrence and control.Patients and methods
This is a prospective observational study con-
ducted in Olaya Medical Center (Riyadh) during
the period from May 2013 to June 2014. The study
protocol was approved by the center’s ethics
committee.
Patients older than 18 years presented to ear,
nose and throat (ENT) clinic were enrolled in the
study after a written consent to participate in the
study. A total of 80 patients were divided into
two groups. Group A consisted of 40 patients
who presented with idiopathic epistaxis. Group
B consisted of 40 patients who served as a control
group. These had presented with other reasons
such as ear pain, headache, and dizziness.
Patients with history of trauma to nose, local
pathology, systemic diseases, bleeding disorders,
patients on aspirin, clopidogrel or anticoagulants,
and children were excluded from the study. None
of the patients was lost to follow-up.Rhinoscopy
Anterior rhinoscopy was done using a nasal
speculum, light source, and a head mirror with
simple inspection. For posterior rhinoscopy, a ton-
gue depressor was placed on the center of the
base of the tongue with one hand, and the base
of the tongue was pressed downward. A small
warmed mirror was then introduced into the
space between the soft palate and posterior pha-
ryngeal wall to inspect the choana, the posterior
ends of the turbinates, the posterior margin of
the septum, and the nasopharynx, together with
its roof and the ostia of the Eustachian tubes.
Nasal sinoscopy was done using 1.7 mm rigid
endoscope (30), light source, camera, and monitor
to evaluate all cases, and to detect site, severity
and management method of epistaxis. Most
patients underwent anterior rhinoscopy and
sinoscopy, whereas posterior rhinoscopy was used
only in a limited number of patients.
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included four methods: first aid (including ante-
rior flexion of the head, control of blood pressure
and fluid replacement if needed and nose pinch-
ing after packing with xylometazoline, provided
the blood pressure is not high), nasal packing with
Merocel, electrocautery, and nasal balloon.
BP measurement
The patient was rested, and then BP was mea-
sured by the authors using a mercuric manometer
in supine position. The first measurement was
taken at presentation before rhinoscopy; the two
other readings were taken 20 min and one hour
after epistaxis control; the first value was rejected
and the final result was calculated as the mean of
the second and the third value.
During the following week, ABPM was initiated
on a 24-h basis by using an Oscar 2, SunTech
Medical, Inc. USA apparatus. The diagnosis of
hypertension was made on the basis of
BPP 140 mmHg systolic and/orP 90 mmHg dia-
stolic or use of antihypertensive medications.
Hypertension by 24-h ambulatory BP was defined
when the mean daytime systolic BP was equal to
or greater than 135 mmHg or when the mean day-
time diastolic BP was equal to or greater than
85 mmHg, according to the report of seventh
report of the 2003 US Hypertension Joint National
Committee, European Society of Hypertension
and European Society of Cardiology guidelines
for hypertension [15].
Patients were followed up for a period of three
months for recurrent attacks of epistaxis and BP
measurement in the same method as mentioned
before. BP values after three months were used
for statistical analysis as an indicator of BP control.
Statistical analysis
Data entry and analysis was performed using
SPSS version 15 software. Continuous and cate-Table 1. Clinical data of patients and control groups.
Epis
Age 50.2
Sex Male patients 27 (6
Female patients 13 (3
DM 15 (3
Smoking 17 (4
History of HTN 10 (2
Duration of HTN in years 13.4
BMI 29.5
DM = diabetes mellitus, HTN = hypertension, BMI = body mass index.gorical variables are presented as mean plus or
minus standard deviation and percentages,
respectively. Mean values between the two groups
were compared using t-test. Comparison between
groups was done by Chi-square test. Pearson’s
correlation coefficient was used to test correlation
between variables. F-test (One-Way Anova) was
used to compare between more than two groups.
A p value 60.05 was considered statistically
significant.Results
We enrolled 80 patients in this study with
mean ± SD age of 47.86 ± 16.01. There were 55
males (68.8%) and 25 females (31.2%), and the
study included 29 diabetic patients (36.3%), 32
smokers (40%) and 23 hypertensive patients
(28.8%). Patients were divided into two groups:
epistaxis group with 40 patients, and control
group with 40 patients.
Table 1 shows non-significant difference
between the two groups regarding all parameters
assessed including age, sex, diabetes, smoking,
BMI, history of hypertension and its duration in
years. Table 2 showed that readings of BP were
similar between the two groups regarding BP at
presentation, ABPM and BP at three months. BP
at presentation was not significantly higher in
patients with epistaxis than control group. Results
of ABPM readings classified patients into stress-
induced hypertension (initial high and normal
ABPM), masked hypertension (initial normal and
high ABPM), pre-existing hypertension, newly
diagnosed hypertension and normal BP. There
were no significant differences between patient
and control groups regarding the final diagnosis
of hypertension.
Management of epistaxis in our patients
included four methods, starting with first aidtaxis group (40) Control group (40) P value
3 ± 16.62 45.5 ± 15.23 0.189
7.5%) 28 (70%) 0.809
2.5%) 12 (30%)
7.5%) 14 (35%) 0.816
2.5%) 15 (37.5%) 0.648
5%) 13 (32.5%) 0.459
± 7.63 10.38 ± 6.19 0.307
6 ± 4.59 28.51 ± 4.98 0.331
Table 4. Blood pressure readings of patients group in relation to the way of management.
First aid (15) Pack (12) Balloon (6) Electrocautery (7) P value
sBP at presentation 126 ± 14.29 143.33 ± 21.57 156.67 ± 29.27 139.29 ± 21.68 0.021
dBP at presentation 80.67 ± 7.04 87.92 ± 9.64 90.83 ± 11.58 86.43 ± 9.88 0.083
ABPM s day 133.13 ± 6.59 160.42 ± 21.67 149.83 ± 16.83 148.86 ± 15.73 0.001
ABPM d day 83 ± 5.3 92.08 ± 8.89 92 ± 11.63 91.86 ± 10.65 0.026
ABPM s night 122.2 ± 9.25 153.75 ± 23.72 141.5 ± 18.01 135.38 ± 20.7 <0.0001
ABPM d night 72.67 ± 7.72 87.58 ± 11.55 85.33 ± 14.21 84.14 ± 13.79 0.007
ABPM s 24 h 131.4 ± 7.37 159.92 ± 21.63 150 ± 16.31 148.74 ± 16.71 <0.0001
ABPM d 24 h 85.67 ± 13.54 90.58 ± 11.19 92 ± 11.56 93 ± 10.91 0.5
sBP 3 months 120.67 ± 11 134.17 ± 13.11 135 ± 5.48 131.43 ± 11.07 0.01
dBP 3 months 76.33 ± 6.67 85.83 ± 5.97 87.5 ± 2.74 82.86 ± 5.67 <0.0001
sBP = systolic blood pressure, dBP = diastolic blood pressure, ABPM = ambulatory blood pressure monitoring, s = systolic, d = diastolic,
HTN = hypertension.
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Table 2. Blood pressure readings and final diagnosis of patients and control group.
Epistaxis group (40) Control group (40) P value
sBP at presentation 138.13 ± 22.47 135.63 ± 19.91 0.6
dBP at presentation 85.38 ± 9.57 83 ± 10.11 0.284
ABPM s day 146.57 ± 18.8 143.6 ± 17.59 0.467
ABPM d day 88.63 ± 9.31 86.58 ± 8.4 0.304
ABPM s night 137.53 ± 21.22 133.23 ± 20.21 0.356
ABPM d night 81.05 ± 12.6 79.15 ± 10.45 0.465
ABPM s 24 Hours 145.78 ± 19.33 142.35 ± 17.53 0.409
ABPM d 24 Hours 89.38 ± 12.07 86.3 ± 11.72 0.251
sBP at 3 months 128.75 ± 12.49 125 ± 10.06 0.143
dBP at 3 months 82 ± 7.32 80.63 ± 6.62 0.381
Final diagnosis Normal 20 (50%) 21 (52.5%) 0.782
Stress HTN 2 (5%) 2 (5%)
Pre-existing HTN 10 (25%) 13 (32.5%)
Masked HTN 6 (15%) 3 (7.5%)
Newly diagnosed HTN 2 (5%) 1 (2.5%)
sBP = systolic blood pressure, dBP = diastolic blood pressure, ABPM = ambulatory blood pressure monitoring, s = systolic, d = diastolic,
HTN = hypertension.
Table 3. Clinical data of patients group in relation to the way of management.
First aid (15) Pack (12) Balloon (6) Electrocautery (7) P value
Age 52.27 ± 18.27 48.75 ± 17.97 45.67 ± 16.61 52.29 ± 12.38 0.842
Sex Male 10 (66.7%) 8 (66.7%) 4 (66.7%) 5 (71.4%) 0.966
Female 5 (33.3%) 4 (33.3%) 2 (33.3%) 2 (28.6%)
Smoking 7 (46.7%) 6 (50%) 3 (50%) 1 (14.3%) 0.423
HTN history 1 (6.7%) 4 (33.3%) 2 (33.3%) 3 (42.9%) 0.208
BMI 30.43 ± 4.57 31.5 ± 4.82 26.6 ± 2.53 26.89 ± 3.7 0.049
DM 7 (46.7%) 4 (33.3%) 2 (33.3%) 2 (28.6%) 0.823
Number of attacks 0 10 (66.7%) 2 (16.7%) 1 (16.7%) 2 (28.6%) 0.041
1 3 (20%) 2 (16.7%) 0 1 (14.3%)
2 2 (13.3%) 5 (41.7%) 5 (83.3%) 3 (42.9%)
3 0 3 (25%) 0 1 (14.3%)
DM = diabetes mellitus, HTN = hypertension, BMI = body mass index.
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cautery [7], and nasal balloon [6].
Table 3 shows non-significant differences
between the various ways of epistaxis manage-
ment regarding age, sex, diabetes, smoking, and
hypertension history. There was a significantly
higher number of attacks in patients managedby more complex interventions such as pack,
electrocautery and balloon than those managed
by first aid. Table 4 shows significantly higher BP
readings in patients managed by more complex
interventions such as pack, electrocautery and
balloon than those managed by first aid, except
for diastolic BP at presentation.
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Association between epistaxis and hypertension
is controversial [16]. Our study was designed to
provide an answer as to whether epistaxis may
be a symptom related to the underlying presence
of arterial hypertension, and to assess the effect of
blood pressure control on epistaxis management.
This study included 80 patients who were
divided into two groups; an epistaxis group and
a control group. Both groups were well matched
for gender, age, smoking habits, BMI and DM.
The BP at presentation in both groups was in the
high normal range, and initial hypertension was
found in 14 patients with epistaxis (35%) and in
16 control patients (40%). Increased blood pres-
sure at presentation may be due to patients’
apprehension at the sight of blood [17]. Kikidis
et al. [18] concluded that the presence of high arte-
rial blood pressure during the actual episode of
nasal bleeding cannot establish a causative rela-
tionship with epistaxis due to confounding stress
and possible white coat phenomenon, but may
lead to initial diagnosis of an already installed
arterial hypertension.
In patients with epistaxis, the final diagnosis of
hypertension was made in 18 patients (45%), with
eight of them unaware of this diagnosis. Two
patients who presented with high BP eventually
had normal BP, whereas in the control group, 17
patients (42.5%) were found to have hypertension,
with four of them unaware of the disease. Another
two patients with initial high BP were found not to
have hypertension. There was no significant dif-
ference between the two groups. These findings
indicate no connection between epistaxis and
hypertension.
The prevalence of hypertension in patients with
epistaxis reportedly ranges from 24% to 64% [19].
Theodosis et al. [5] found that the final diagnosis
of hypertension was set in 42.9% of patients
admitted with epistaxis and in 28.9% of controls,
which was not a statistically significant difference.
Also, Nash and Field [11] found that history of
hypertension was noted in 43.7% of patients, of
whom 40.5% were receiving antihypertensive
medications. Similarly, Page et al. [10] found that
55% of patients with epistaxis had a history of
hypertension versus 48% for Viducich et al. [20]
and 47% for Pollice and Yoder [21].
Our study showed that, in patients with epi-
staxis, the final there was no significant difference
between male and female patients regarding BP
readings. Further, the number of attacks over three
months showed no significant correlation with age,sex, BMI, or smoking. The number of attacks was
significantly higher in hypertensive patients; and
in addition, there was a highly significant positive
correlation between the number of attacks and
BP readings including BP at presentation, ABPM
and BP at three months. This indicates that
uncontrolled hypertension is associated with more
attacks of epistaxis and also that epistaxis may be
difficult to control in patients with uncontrolled
hypertension.
Systolic BP at presentation was significantly
higher in patients who needed more complex
interventions such as pack, balloon or cautery
than patients managed by first aid. This indicates
that hypertension renders the management of
epistaxis more difficult. Diastolic pressure was
not significantly different. Similar results were
found for ABPM readings, except for diastolic BP
over the 24 h.
Our results were in agreement with Theodosis
et al. [5] who found that patients admitted with
epistaxis had elevated systolic pressures com-
pared to controls, but no difference regarding
the final diagnosis of hypertension, which indi-
cates no connection between epistaxis and hyper-
tension. Our results are also in agreement with
Fuchs et al. [22] who found that hypertension is
not associated with history of epistaxis in the
adulthood. Similar results were drawn by Karras
et al. [23] in a population of 1908 individuals. Lubi-
anca Neto et al. [14] found no definite association
between blood pressure and history of adult epi-
staxis in hypertensive patients. Yüksel et al. [24]
found that the evidence available was insufficient
to prove a significant association between hyper-
tension and epistaxis. Lima and Knopfholz [25]
reported that epistaxis was unlikely to be a hyper-
tensive emergency. Gifford and Orlandi [26]
found that the control of epistaxis may be more
difficult in patients with hypertension.
Our results were in contrast with the results of
Herkner et al. [27] who found that patients with
epistaxis have a higher blood pressure compared
to that of control patients. Isezuo et al. [7] also
found an association between epistaxis and
hypertension.
In conclusion, we found no definite association
between epistaxis and hypertension. The initial
high BP may be explained by confounding stress
and white coat effect; however, we found no dif-
ference between the patients and control groups,
and no difference regarding BP readings and the
final diagnosis of hypertension. All these findings
clearly show a non-association between epistaxis
and hypertension.
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staxis was higher in hypertensive patients, and
higher BP made the management of epistaxis
more complex, indicating that epistaxis was more
difficult to control in hypertensive patients.
To the best of our knowledge, data assessing the
correlation between blood pressure readings and
management of epistaxis is scarce, and our study
may be the first to address this correlation.
Our study limitations include a small number of
patients and the short duration of follow-up. A
larger study with more prolonged follow-up is
needed to address the link between hypertension
and epistaxis and whether a cause and effect rela-
tion exists.Conclusion
We demonstrated that there is no association
between hypertension and epistaxis, and that epi-
staxis was not initiated by high BP. However, epi-
staxis was more difficult to control in hypertensive
patients. Due to the limited number of patients
and short duration of follow-up, larger studies
are needed to fully address this problem.
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